Literature DB >> 26374444

Antidepressant use in late gestation and risk of postpartum haemorrhage: a retrospective cohort study.

L E Grzeskowiak1, R McBain2, G A Dekker3,2, V L Clifton3.   

Abstract

OBJECTIVE: To investigate the association between antidepressant use in late gestation and postpartum haemorrhage (PPH).
DESIGN: Retrospective cohort study.
SETTING: Tertiary teaching hospital in Adelaide, Australia. POPULATION: A total of 30 198 women delivering between 2002 and 2008.
METHODS: Relative risks adjusted for maternal sociodemographics and comorbidities (aRRs) were calculated for PPH, comparing women with late-gestation exposure to antidepressants (n = 558), women with a psychiatric illness but no antidepressant use (n = 1292), and women with neither antenatal exposures (n = 28 348). Additional sensitivity analyses were undertaken, examining associations with severe PPH and postpartum anaemia. MAIN OUTCOME MEASURES: The primary outcome was PPH, defined as a recorded blood loss of ≥500 mL for vaginal deliveries and ≥1000 mL for caesarean sections. Secondary outcomes included severe PPH (≥1000 mL blood loss, irrespective of method of delivery), and the presence of postpartum anaemia (identified from hospital medical records).
RESULTS: Compared with unexposed controls, women exposed to antidepressants had an increased risk of PPH (aRR 1.53; 95% confidence interval, 95% CI 1.25-1.86), whereas no increased risk was observed for women with a psychiatric illness but no antidepressant use (aRR 1.04; 95% CI 0.89-1.23). In sensitivity analyses, late gestation antidepressant exposure was associated with an increased risk of severe PPH (aRR 1.84; 95% CI 1.39-2.44), as well as postpartum anaemia (aRR 1.80; 95% CI 1.46-2.22).
CONCLUSIONS: Exposure to antidepressants in late gestation was associated with a significantly increased risk of PPH. Although potential confounding by unmeasured factors cannot be ruled out, these findings suggest a direct effect of antidepressant exposure on PPH. TWEETABLE ABSTRACT: Late gestation antidepressant exposure is associated with a significantly increased risk of postpartum haemorrhage.
© 2015 Royal College of Obstetricians and Gynaecologists.

Entities:  

Keywords:  Antidepressive agents; postpartum haemorrhage; pregnancy; prenatal exposure; selective serotonin reuptake inhibitors

Mesh:

Substances:

Year:  2015        PMID: 26374444     DOI: 10.1111/1471-0528.13612

Source DB:  PubMed          Journal:  BJOG        ISSN: 1470-0328            Impact factor:   6.531


  5 in total

1.  Impact of serotonin reuptake inhibitor use on breast milk supply in mothers of preterm infants: a retrospective cohort study.

Authors:  Luke E Grzeskowiak; Catherine Leggett; Lynn Costi; Claire T Roberts; Lisa H Amir
Journal:  Br J Clin Pharmacol       Date:  2018-04-14       Impact factor: 4.335

2.  Is third trimester serotonin reuptake inhibitor use associated with postpartum hemorrhage?

Authors:  Deborah R Kim; Emily Pinheiro; James F Luther; Heather F Eng; John L Dills; Stephen R Wisniewski; Katherine L Wisner
Journal:  J Psychiatr Res       Date:  2015-11-19       Impact factor: 4.791

3.  Patterns of prenatal antidepressant exposure and risk of preeclampsia and postpartum haemorrhage.

Authors:  Kristin Palmsten; Christina D Chambers; Alan Wells; Gretchen Bandoli
Journal:  Paediatr Perinat Epidemiol       Date:  2020-03-24       Impact factor: 3.980

Review 4.  Recent advances in understanding maternal perinatal mood disorders.

Authors:  Thalia Robakis; Eugenia Jernick; Katherine Williams
Journal:  F1000Res       Date:  2017-06-15

5.  Increased postpartum haemorrhage, the possible relation with serotonergic and other psychopharmacological drugs: a matched cohort study.

Authors:  Hanna M Heller; Anita C J Ravelli; Andrea H L Bruning; Christianne J M de Groot; Fedde Scheele; Maria G van Pampus; Adriaan Honig
Journal:  BMC Pregnancy Childbirth       Date:  2017-06-02       Impact factor: 3.007

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.